Definitive Healthcare Corp. a leading provider of healthcare commercial intelligence, has recently announced that its Board of Directors granted inducement awards to their new Chief Executive Officer and board member, Kevin Coop. The awards include 1,137,038 performance-based restricted stock units (PSUs) and 1,170,047 time-based restricted stock units (RSUs), effective from June 24, 2024. This move is considered an inducement material to Mr. Coop’s employment commencement, following Nasdaq Listing Rule 5635(c)(4).
Despite this positive development, the company has encountered financial challenges. Definitive Healthcare Corp. recorded a cumulative net loss of $238 million during the 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -10.13%.
Comments